The recent COVID-19 pandemic has resulted in consequences which have rippled across the health care setting and beyond. As we resume elective surgery, clinicians are adapting their postoperative practice to achieve low-touch care, including early discharge and home based recovery.
PREVENA™ Therapy enables low-touch care, whilst helping reduce the risk of surgical site complications, including infection. The portable device is easily managed by the patient at home for up to 7 days. Allowing hospitals to free up vital capacity for those patients that need it the most.
PREVENA™ Therapy is supported by over 70+ studies across multiple specialties. Designed to protect the surgical incision and reduce the risk of surgical site complications, including infection. Helping to reduced the burden of these complications such as increased costs, resource constraints and readmissions to hospitals and clinical teams.
Learn more about PREVENA™ Therapy in your specialty. Discover how the therapy works, how to select appropriate patients, an overview of clinical evidence and case studies from your specialty.
Whether you would like a free PREVENA™ Therapy Trial or would like more information, simply fill in the form below and a 3M representative will be in touch.
Your form was submitted successfully!
An error has occurred while submitting. Please try again later...
The brands listed above are trademarks of 3M.